The goal of the Oxidative Damage and Mitochondrial Function Core is two-fold. First, we will continue to provide measurement of oxidative damage to lipid, DNA and protein in cells and tissues using the latest and most sensitive methods and technologic approaches. The second and new function of the Core is to provide several key assays of mitochondrial function including measures of reactive oxygen species generation, respiration and ATP production in isolated mitochondria and in cultured cells. Compromised mitochondrial function and accumulation of oxidative damage to cell components with age have been proposed as primary factors underlying age-associated alterations in physiologic function and pathology. A number of recent studies have suggested that the relation between mitochondrial dysfunction, oxidative damage and aging may not be as straightforward as originally proposed by Hamian more than 50 years ago. However, measures of oxidative damage and mitochondrial function continue to be important components of many studies on the underlying mechanisms of aging and age-related disease, and it is critical that these measures are done with the highest possible sensitivity and accuracy. The measurements offered by the Core require costly equipment and technologic expertise that prevent these types of analyses as routine measures in individual laboratories.
The Specific Aims of the Oxidative Damage and Mitochondrial Function Core are as follows: 1. To provide sensitive and accurate measurements of oxidative damage to lipids, DNA and protein through analysis of F2-isoprostanes/isofurans (lipid oxidation), 8-oxo-2-deoxyguanosine (oxo8dG) (DNA oxidation), and oxidative modifications to proteins (carbonyls, disulfide content and alterations in protein hydrophobicity). 2. To provide high quality sensitive measurement of mitochondrial function in isolated mitochondria and cell culture using state-of-the-art techniques. 3. To provide education and consultation regarding methodology for assessing oxidative damage and mitochondrial function.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-2)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Health Science Center
San Antonio
United States
Zip Code
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Kang, Donghoon; Kirienko, Daniel R; Webster, Phillip et al. (2018) Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence 9:804-817
Hook, Michael; Roy, Suheeta; Williams, Evan G et al. (2018) Genetic cartography of longevity in humans and mice: Current landscape and horizons. Biochim Biophys Acta Mol Basis Dis 1864:2718-2732
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918

Showing the most recent 10 out of 231 publications